Cladribine and Ocrelizumab induce differentially modulated microRNA profiles in mononucleated blood cells from relapsing-remitting Multiple Sclerosis patients

被引：0
|
作者：
Arisi, Ivan [1 ]
Malimpensa, Leonardo [2 ]
Manzini, Valeria [2 ]
Brandi, Rossella [3 ]
D'Amelio, Chiara [4 ]
di Sturmeck, Tommaso Gosetti [1 ]
Crisafulli, Sebastiano [5 ]
Ferrazzano, Gina [2 ]
Belvisi, Daniele [2 ]
Malerba, Francesca [1 ]
Florio, Rita [1 ]
Pascale, Esterina [2 ]
Soreq, Hermona [6 ,7 ]
Salvetti, Marco [2 ]
Cattaneo, Antonino [1 ]
D'Onofrio, Mara [1 ]
Conte, Antonella [2 ]
机构：
[1] EBRI, European Brain Res Inst Rita Levi Montalcini, Rome, Italy
[2] Univ Roma La Sapienza, Rome, Italy
[3] Sci Dept Army Med Ctr, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Rome, Italy
[5] Multiple Sclerosis Ctr, Milan, Italy
[6] Hebrew Univ Jersusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel
[7] Hebrew Univ Jersusalem, Inst Life Sci, Jerusalem, Israel
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1415/1877
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [21] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Cavit Boz
    Serkan Ozakbas
    Murat Terzi
    Rana Karabudak
    Serhan Sevim
    Recai Turkoglu
    Aysun Soysal
    Belgin Petek Balcı
    Hüsnü Efendi
    Ömer Faruk Turan
    Nur Yüceyar
    Mehmet Fatih Yetkin
    Serap Zengin Karahan
    Meltem Demirkıran
    Sibel Guler
    Kadriye Agan
    Nefati Kıylıoğlu
    Cavid Baba
    Asli Tuncer
    Mesrure Köseoğlu
    Neurological Sciences, 2023, 44 : 2121 - 2129
  • [22] Ocrelizumab Alters the Circulating Metabolome in People with Relapsing-remitting Multiple Sclerosis
    Siavoshi, Fatemeh
    Ladakis, Dimitrios C.
    Muller, Ashley
    Nourbakhsh, Bardia
    Bhargava, Pavan
    ANNALS OF NEUROLOGY, 2024, 96 : S92 - S93
  • [23] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Ozakbas, Serkan
    Terzi, Murat
    Karabudak, Rana
    Sevim, Serhan
    Turkoglu, Recai
    Soysal, Aysun
    Balci, Belgin Petek
    Efendi, Husnu
    Turan, Omer Faruk
    Yuceyar, Nur
    Yetkin, Mehmet Fatih
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Guler, Sibel
    Agan, Kadriye
    Kiylioglu, Nefati
    Baba, Cavid
    Tuncer, Asli
    Koseoglu, Mesrure
    NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
  • [24] Ocrelizumab alters the circulating metabolome in people with relapsing-remitting multiple sclerosis
    Siavoshi, Fatemeh
    Ladakis, Dimitrios C.
    Muller, Ashley
    Nourbakhsh, Bardia
    Bhargava, Pavan
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (09): : 2485 - 2498
  • [25] Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells
    Ammoscato, Francesca
    Wafa, Mohammad
    Skonieczna, Justyna
    Bestwick, Jonathan
    Monero, Rosemary
    Andrews, Michael
    De Trane, Stefania
    Holden, David
    Adams, Ashok
    Bianchi, Lucia
    Turner, Ben
    Marta, Monica
    Schmierer, Klaus
    Baker, David
    Giovannoni, Gavin
    Gnanapavan, Sharmilee
    CLINICAL IMMUNOLOGY, 2024, 269
  • [26] Ocrelizumab Alters the Circulating Metabolome in People with Relapsing-remitting Multiple Sclerosis
    Siavoshi, Fatemeh
    Ladakis, Dimitrios
    Muller, Ashley
    Nourbakhsh, Bardia
    Bhargava, Pavan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 40 - 40
  • [27] Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Kornilov, Sergey A.
    Price, Nathan D.
    Gelinas, Richard
    Acosta, Juan
    Brunkow, Mary E.
    Gervasi-Follmar, Tiffany
    Winger, Ryan C.
    Aldershoff, Dmitri
    Lausted, Christopher
    Troisch, Pamela
    Smith, Brett
    Heath, James R.
    Repovic, Pavle
    Cohan, Stanley
    Magis, Andrew T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 467
  • [28] Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's Review
    Giovannoni, Gavin
    Mathews, Joela
    NEUROLOGY AND THERAPY, 2022, 11 (02) : 571 - 595
  • [29] Prevalence of disability improvement in relapsing-remitting multiple sclerosis patients treated with cladribine tablets
    Signori, Alessio
    Ponzano, Marta
    Alexandri, Nektaria
    Giovannoni, Gavin
    Sormani, Maria Pia
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (07) : 2144 - 2147
  • [30] Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
    Boldrini, Vinicius O.
    Marques, Ana M.
    Quintiliano, Raphael P. S.
    Moraes, Adriel S.
    Stella, Carla R. A. V.
    Longhini, Ana Leda F.
    Santos, Irene
    Andrade, Marilia
    Ferrari, Breno
    Damasceno, Alfredo
    Carneiro, Rafael P. D.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Santos, Leonilda M. B.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345